Poloxamer-188 and citicoline provide neuronal membrane integrity and protect membrane stability in cortical spreading depression

References

• Strong AJ, Fabricius M, Boutelle MG, et al. Spreading and synchronous depressions of cortical activity in acutely injured human brain. Stroke. 2002;33(12):2738–2743.
   PubMed Web of Science ®Google Scholar
• Dohmen C, Sakowitz OW, Fabricius M, et al. Co-Operative Study of Brain Injury Depolarisations (COSBID). Spreading depolarizations occur in human ischemic stroke with high incidence. Ann Neurol. 2008;63(6):720–8.
   PubMed Web of Science ®Google Scholar
• Lauritzen M, Dreier JP, Fabricius M, et al. Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. J Cereb Blood Flow Metab. 2011;31(1):17–35.
   PubMed Web of Science ®Google Scholar
• Pietrobon D, Moskowitz MA. Pathophysiology of migraine. Annu Rev Physiol. 2013;75:365–91.
   PubMed Web of Science ®Google Scholar
• Lauritzen M. Cortical spreading depression in migraine. Cephalalgia. 2001;21(7):757–60.
   PubMed Web of Science ®Google Scholar
• Dalkara T, Zervas NT, Moskowitz MA. From spreading depression to the trigeminovascular system. Neurol Sci. 2006;27(Suppl 2):S86–90.
   PubMed Web of Science ®Google Scholar
• Charles A, Brennan K. Cortical spreading depression-new insights and persistent questions. Cephalalgia. 2009;29(10):1115–24.
   PubMed Web of Science ®Google Scholar
• Gorji A. Spreading depression: a review of the clinical relevance. Brain Res Brain Res Rev. 2001;38(1–2):33–60.
   PubMed Web of Science ®Google Scholar
• Somjen GG. Mechanisms of spreading depression and hypoxic spreading depression like depolarization. Physiol Rev. 2001;81:1065–96.
   PubMed Web of Science ®Google Scholar
• Nedergaard M, Hansen AJ. Spreading depression is not associated with neuronal injury in the normal brain. Brain Res. 1988;449(1–2):395–8.
   PubMed Web of Science ®Google Scholar
• Hopwood SE, Parkin MC, Bezzina EL, et al. Transient changes in cortical glucose and lactate levels associated with peri-infarct depolarisations, studied with rapid-sampling microdialysis. J Cereb Blood Flow Metab. 2005;25(3):391–401.
   PubMed Web of Science ®Google Scholar
• Parkin M, Hopwood S, Jones DA, et al. Dynamic changes in brain glucose and lactate in pericontusional areas of the human cerebral cortex, monitored with rapid sampling on-line microdialysis: relationship with depolarisation-like events. J Cereb Blood Flow Metab. 2005;25(3):402–13.
   PubMed Web of Science ®Google Scholar
• Dreier JP. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med. 2011;17(4):439–47.
   PubMed Web of Science ®Google Scholar
• Ayata C. Spreading depression: from serendipity to targeted therapy in migraine prophylaxis. Cephalalgia. 2009;29(10):1095–114.
   PubMed Web of Science ®Google Scholar
• Gursoy-Ozdemir Y, Qiu J, Matsuoka N, et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest. 2004;113(10):1447–55.
   PubMed Web of Science ®Google Scholar
• Mies G, Iijima T, Hossmann KA. Correlation between peri-infarct DC shifts and ischaemic neuronal damage in rat. Neuroreport. 1993;4(6):709–11.
   PubMed Web of Science ®Google Scholar
• Borgens RB, Bohnert D, Duerstock B, et al. Subcutaneous tri-block copolymer produces recovery from spinal cord injury. J Neurosci Res. 2004;76(1):141–54.
   PubMed Web of Science ®Google Scholar
• Curry DJ, Wright DA, Lee RC, et al. Surfactant poloxamer 188-related decreases in inflammation and tissue damage after experimental brain injury in rats. J Neurosurg. 2004;101(1 Suppl):91–6.
   PubMed Web of Science ®Google Scholar
• Luo CL, Chen XP, Li LL, et al. Poloxamer 188 attenuates in vitro traumatic brain injury-induced mitochondrial and lysosomal membrane permeabilization damage in cultured primary neurons. J Neurotrauma. 2013;30(7):597–607.
   PubMed Web of Science ®Google Scholar
• Bao HJ, Wang T, Zhang MY, et al. Poloxamer-188 attenuates TBI-induced blood-brain barrier damage leading to decreased brain edema and reduced cellular death. Neurochem Res. 2012;37(12):2856–67.
   PubMed Web of Science ®Google Scholar
• Serbest G, Horwitz J, Jost M, Barbee K. Mechanisms of cell death and neuroprotection by poloxamer 188 after mechanical trauma. FASEB J. 2006;20(2):308–10.
   PubMed Web of Science ®Google Scholar
• D'Orlando KJ, Sandage BW Jr. Citicoline (CDP-choline): mechanisms of action and effects in ischemic brain injury. Neurol Res. 1995;17(4):281–4.
   PubMed Web of Science ®Google Scholar
• Rao AM, Hatcher JF, Dempsey RJ. Lipid alterations in transient forebrain ischemia: possible new mechanisms of CDP-cholineneuroprotection. J Neurochem. 2000;75(6):2528–35.
   PubMed Web of Science ®Google Scholar
• Adibhatla RM, Hatcher JF. Citicoline mechanisms and clinical efficacy in cerebral ischemia. J Neurosci Res. 2002;70(2):133–9.
   PubMed Web of Science ®Google Scholar
• Dunn AK, Bolay H, Moskowitz MA, Boas DA. Dynamic imaging of cerebral blood flow using laser speckle. J Cereb Blood Flow Metab. 2001;21(3):195–201.
   PubMed Web of Science ®Google Scholar
• Karatas H, Erdener SE, Gursoy-Ozdemir Y, et al. Spreading depression triggers headache by activating neuronal Panx1 channels. Science. 2013;339(6123):1092–5.
   PubMed Web of Science ®Google Scholar
• Maskarinec SA, Wu G, Lee KY. Membrane sealing by polymers. Ann NY Acad Sci. 2005;1066:310–20.
   PubMed Web of Science ®Google Scholar
• Mezrow CK, Mazzoni M, Wolfe D, et al. Poloxamer 188 improves neurologic outcome after hypothermic circulatory arrest. J Thorac Cardiovasc Surg. 1992;103(6):1143–6.
   PubMed Web of Science ®Google Scholar
• Curry DJ, Wright DA, Lee RC, et al. Poloxamer 188 volumetrically decreases neuronal loss in the rat in a time-dependent manner. Neurosurgery. 2004;55(4):943–8; discussion 948–9.
   PubMed Web of Science ®Google Scholar
• Hunter RL, Luo AZ, Zhang R, et al. Poloxamer 188 inhibition of ischemia/reperfusion injury: evidence for a novel anti-adhesive mechanism. Ann Clin Lab Sci. 2010;40(2):115–25.
   PubMed Web of Science ®Google Scholar
• Zhang R, Hunter RL, Gonzalez EA, Moore FA. Poloxamer 188 prolongs survival of hypotensive resuscitation and decreases vital tissue injury after full resuscitation. Shock. 2009;32(4):442–50.
   PubMed Web of Science ®Google Scholar
• Justicz AG, Farnsworth WV, Soberman MS, et al. Reduction of myocardial infarct size by poloxamer 188 and mannitol in a canine model. Am Heart J. 1991;122(3 Pt 1):671–80.
   PubMed Web of Science ®Google Scholar
• Juneman EB, Saleh L, Lancaster JJ, et al. The effects of poloxamer-188 on left ventricular function in chronic heart failure after myocardial infarction. J Cardiovasc Pharmacol. 2012;60(3):293–8.
   PubMed Web of Science ®Google Scholar
• Frim DM, Wright DA, Curry DJ, et al. The surfactant poloxamer-188 protects against glutamate toxicity in the rat brain. Neuroreport. 2004;15(1):171–4.
   PubMed Web of Science ®Google Scholar
• Fischer SM, Brandl M, Fricker G. Effect of the non-ionic surfactant Poloxamer 188 on passive permeability of poorly soluble drugs across Caco-2 cell monolayers. Eur J Pharm Biopharm. 2011;79(2):416–22.
   PubMed Web of Science ®Google Scholar
• Takasaki K, Uchida K, Fujikawa R, et al. Neuroprotective effects of citidine-5-diphosphocholine on impaired spatial memory in a rat model of cerebrovascular dementia. J Pharmacol Sci. 2011;116(2):232–7.
   PubMed Web of Science ®Google Scholar
• Hurtado O, Pradillo JM, Fernández-López D, et al. Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke. Neurobiol Dis. 2008;29(1):123–31.
   PubMed Web of Science ®Google Scholar
• Rao AM, Hatcher JF, Dempsey RJ. CDP-choline: neuroprotection in transient forebrain ischemia of gerbils. J Neurosci Res. 1999;58(5):697–705.
   PubMed Web of Science ®Google Scholar
• Guldali O, Savci V, Buyukafsar K. CDP-choline-induced contractions in the mouse gastric fundus through purinoceptors and Rho/Rho-kinase signalling. Life Sci. 2011;88(11–12):473–9.
   PubMed Web of Science ®Google Scholar
• Dahl G, Qiu F, Wang J. The bizarre pharmacology of the ATP release channel pannexin1. Neuropharmacology. 2013;75:583–93.
   PubMed Web of Science ®Google Scholar